Cart summary

You have no items in your shopping cart.

BAPTA-AM

SKU: orb1300942

Description

BAPTA-AM is a cell-permeable calcium chelator with high selectivity for Ca²⁺ over Mg²⁺. It is widely used in vitro to investigate calcium-dependent signaling pathways and can also inhibit hERG, hKv1.3, and hKv1.5 potassium channels at micromolar concentrations.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number126150-97-8
MW764.68
Purity99.09%
FormulaC34H40N2O18
SMILESCC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccccc1OCCOc1ccccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O
TargetPotassium Channel
Solubility10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (3.27 mM);DMSO:50 mg/mL (65.39 mM)

Bioactivity

Target IC50
ERG channel (human, HEK293 cells):1.3 μM|Kv1.5 channel (human, HEK293 cells):1.23 μM|Kv1.3 channel (human, HEK293 cells):1.45 μM
In Vivo
METHODS: To investigate the effect on ethanol-induced locomotor activity, BAPTA-AM (0-10 mg/kg, Cremophor EL 1.25% (v/v) in distilled water) was injected intraperitoneally into Swiss (RjOrl) mice, followed by ethanol (0-4 g/kg) 30 min later. RESULTS: Pretreatment with BAPTA-AM blocked the locomotor stimulus produced by ethanol without altering basal locomotion. On the contrary, BAPTA-AM reversed the ethanol-induced hypnosis. METHODS: To investigate the effect on LPS-induced blood-brain barrier leakage, BAPTA-AM (12 mg/kg, 0.01% pluronic acid in sterile saline) was injected intravenously into FVB mice, followed 30 min later by intraperitoneal injection of LPS (25 mg/kg). RESULTS: BAPTA-AM reduced LPS-induced blood-brain barrier leakage.
In Vitro
METHODS: Chondrocytes were treated with BAPTA-AM (10 μM) and FAC (100 μM) for 24 h. Intracellular ROS levels were measured using the Reactive Oxygen Species Assay kit. RESULTS: FAC promoted ROS production and this effect was inhibited by the calcium chelator BAPTA-AM. METHODS: Rat fibroblast RAT2 and Xenopus cells were treated with BAPTA-AM (50 μM) for 1 h, and microtubule depolymerization was detected by Immunostaining. RESULTS: BAPTA AM treatment for 30 min resulted in almost complete disassembly in most cells, and microtubules were uniformly depolymerized in cells within 60 min.
Cell Research
Instructions for use I. Solution preparation 1. Prepare BAPTA-AM storage solution: Dissolve BAPTA-AM in anhydrous DMSO to prepare a 50 mM storage solution; (it is recommended to store at -20 ℃ or -80 ℃ in the dark after aliquoting). 2. Prepare working solution: Dilute BAPTA-AM storage solution into cell culture medium to a final concentration of 6-50 μM. II. Cell preparation 1. Grow cells to an appropriate density. For adherent cells, they can be planted in culture dishes or culture plates; for suspended cells, adjust the cell concentration to 2×10^6 cells/mL. 2. Incubate cells with BAPTA-AM solution, usually at 37℃, 5% CO₂ for 30-60 minutes, with gentle shaking during the period. 3. Remove excess dye: After incubation, wash cells with calcium-free buffer to remove BAPTA-AM that has not entered the cells. 4. For adherent cells, they can be directly washed with calcium-free PBS; for suspended cells, the cells need to be collected by centrifugation and then resuspended with calcium-free PBS. 5. Detection of changes in calcium ion concentration: You can choose the appropriate detection method according to the experimental requirements: Fluorescence microscope detection: observe the changes in fluorescence intensity in cells. The decrease in fluorescence intensity indicates a decrease in calcium ion concentration. Flow cytometry detection: analyze the changes in fluorescence intensity in cells through flow cytometry. Fluorescence spectrometer detection: measure the changes in fluorescence intensity of cell suspension.

Storage & Handling

Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

PotassiumChannel, Potassium Channel, BAPTA AM, BAPTA/AM, BAPTAAM, BAPTA-AM, KcsA, inhibit, Inhibitor

Similar Products

  • BAPTA tetrapotassium [orb1685095]

    97.41%

    73630-08-7

    628.79

    C22H20K4N2O10

    200 mg, 100 mg
  • BAPTA-AM [orb1226651]

    >98%(HPLC)

    126150-97-8

    764.7

    C34H40N2O18

    1 g, 500 mg, 200 mg, 100 mg, 5 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

BAPTA-AM (orb1300942)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 70.00
1 ml x 10 mM (in DMSO)
$ 90.00
10 mg
$ 100.00